Home » Topics » BioWorld Science

BioWorld Science
RSS

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Marimastat enters phase II in U.S.

March 15, 1996

IDEC-C2B8 development update

March 15, 1996

Virogenetics cancer vaccine in phase I/II trials

March 15, 1996

Techniclone establishes distribution agreement for Oncolym

March 15, 1996

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

More approvals for Taxotere

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

FDA gives green light to Immunex's etoposide

March 15, 1996

European clinical trial results with irinotecan reported

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...